Zoetis Inc., a global leader in animal health, has unveiled its latest breakthrough in veterinary diagnostics: AI Masses, a powerful new feature on the Vetscan Imagyst® analyzer that delivers rapid, in-clinic screening of lymph node and skin/subcutaneous lesions. Designed to identify potentially neoplastic (cancerous) cells with high accuracy, this technology significantly enhances the ability of veterinary professionals to make fast, informed decisions during critical patient evaluations.